Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
The question of whether nicotine, the neuroactive compound of tobacco, is addictive has been open to considerable scientific and public discussion. Although it can serve as a positive reinforcer in several animal species, including man, nicotine is thought to be a weak reinforcer in comparison with addictive drugs such as cocaine and heroin, and has been argued to be habit forming but not addictive. Here we report that intravenous nicotine in the rat, at doses known to maintain self-administration, stimulates local energy metabolism, as measured by 2-deoxyglucose autoradiography, and dopamine transmission, as estimated by brain microdialysis, in the shell of the nucleus accumbens. These neurochemical and metabolic effects are qualitatively similar to those of other drugs, such as cocaine, amphetamine and morphine, which have strong addictive properties. Our results provide functional and neurochemical evidence that there are specific neurobiological commonalities between nicotine and addictive drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nicotine elicits its psychoactive effects by activating neuromediators centrally (e.g. dopamine, serotonin, the catecholamines, etc.).”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Nicotine’s mode of action includes both psychostimulatory and sympathomimetic effects.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Specifically, dopamine-rich brain regions representing the appetitive value of potential rewards such as the ventral striatum (Carlezon & Wise, 1996; Pontieri, Tanda, Orzi, & DiChiara, 1996; Wise, 2004; Galvan, et al., 2005; Haber & Knutson, 2009; Spicer, et al., 2007) show strong signaling during adolescence which may be indicative of earlier maturation (Galvan, et al., 2006; Geier, Terwilliger,”
From Frontostriatal maturation predicts cognitive control failure to appetitive cues in adolescents (2011) · cites this paper as Pontieri, Tanda, Orzi, & DiChiara, 1996
In the citing paper
“Nicotine administration leads to increased dopamine cell firing in the ventral tegmental area [15] and increased dopamine release in the nucleus accumbens [52], actions which are thought to be critical to the properties of nicotine as an addictive drug.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Handbook of Psychopharmacology
(1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,746
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes
Tiffany, S. T. (1990) · Psychological Review · doi:10.1037/0033-295x.97.2.147 · Cited by 1,554
Specificity in the projection patterns of accumbal core and shell in the rat
Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W., & Wohltmann, C. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90202-y · Cited by 1,219
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Pontieri, F. E., Tanda, G., & Di Chiara, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12304 · Cited by 868
Self-citation
Research works printed but not linked: 1
- Orzi, F. et al. Eur. J. Pharmac. (in the press).
Cited by
Items 601–700 of 1,000
Addiction research in a simple animal model: the nematode Caenorhabditis elegans
Schafer, W. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.026 · Cited by 28
Reward related neurotransmitter changes in a model of depression: An in vivo microdialysis study
Kučerová, J., Amchová, P., Havlickova, T., Jerabek, P., Babinská, Z., Kačer, P., Syslová, K., Šulcová, A., & Šustková-Fišerová, M. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1077991 · Cited by 30
“This was shown for cannabinoids, opioids (Tanda et al. 1997), psychostimulants (Pontieri et al. 1995) and nicotine (Pontieri et al. 1996).”
BackgroundReducing behavioural risk factors for cancer: An affect regulation perspective
O’Leary, D., Suri, G., & Gross, J. J. (2017) · Psychology and Health · doi:10.1080/08870446.2017.1314480 · Cited by 27
CIGARETTE SMOKING AND DEPRESSIVE SYMPTOMS: A LONGITUDINAL STUDY OF ADOLESCENTS AND YOUNG ADULTS
BROOK, J. S. (2004) · Psychological Reports · doi:10.2466/pr0.95.5.159-166 · Cited by 26
Redden, D. T., Shields, P. G., Epstein, L., Wileyto, E. P., Zakharkin, S. O., Allison, D. B., & Lerman, C. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0649 · Cited by 26
“Because nicotine stimulates the secretion of dopamine into the neuronal synapse (18), we hypothesized that smokers who carried the high activity (H) allele and who therefore may have lower levels of dopamine, would experience a different level of reward from nicotine and possibly be more or less nicotine dependent.”
BackgroundIto, M., Nagai, T., Kamei, H., Nakamichi, N., Nabeshima, T., Takuma, K., & Yamada, K. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.022467 · Cited by 27
“in the NAc (Koob and Weiss, 1992; Pontieri et al., 1996).”
BackgroundFunctional correlates of nicotine administration: similarity with drugs of abuse
Pontieri, F. E., Passarelli, F., Calò, L., & Caronti, B. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050208 · Cited by 27
“See [47] for details on the study &/f ig.”
BackgroundResultInfluentialSelf-citationPsychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?
Hersey, M., Bacon, A. K., Bailey, L. G., Coggiano, M. A., Newman, A. H., Leggio, L., & Tanda, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.656475 · Cited by 25
“, 2016) (summarized in Table 2) like abused psychostimulants (Nisell et al., 1994; Pontieri et al., 1996; Munzar et al., 2004; Kohut et al., 2014).”
BackgroundSelf-citationSouter, E. A., Chen, Y.-C., Zell, V., Lallai, V., Steinkellner, T., Conrad, W. S., Wisden, W., Harris, K. D., Fowler, C. D., & Hnasko, T. S. (2021) · eNeuro · doi:10.1523/eneuro.0481-21.2021 · Cited by 28
“Within the mesolimbic circuit, including ventral tegmental area dopamine neuron projections to nucleus accumbens, activation of nAChRs contribute to the rewarding effect of nicotine (Calabresi et al., 1989; Pontieri et al., 1996; Mansvelder and McGehee, 2000; Pons et al., 2008; Liu et al., 2012; Peng et al., 2017; Gri…”
BackgroundAge-related effects of acute nicotine on behavioural and neuronal measures of anxiety
Kupferschmidt, D. A., Funk, D. R., Erb, S. M., & Lê, A. D. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.05.022 · Cited by 25
A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats
Boules, M., Oliveros, A., Liang, Y., Williams, K., Shaw, A. M., Robinson, J. L. L., Fredrickson, P. A., & Richelson, E. (2010) · Neuropeptides · doi:10.1016/j.npep.2010.09.003 · Cited by 27
“…DA system is thought to be critical to the reinforcing and addictive properties of nicotine (Balfour et al., 2000; Di Chiara, 2000), which similar to other psychostimulants, increases the release of DA from terminal fields of the mesolimbic DA system (Pontieri et al., 1996; Balfour et al., 1998).”
BackgroundWang, J., Gutala, R. V., Hwang, Y. Y., Kim, J. ‐., Konu, Ö., Ma, J. Z., & Li, M. D. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00328.x · Cited by 26
“Animal studies have indicated that nicotine, like other drugs of abuse, stimulates dopamine secretion in the outer shell of the nucleus accumbens (NA) (Pontieri et al. 1996; Robbins & Everitt 1999).”
BackgroundWang, J., Kim, J.-M., Donovan, D. M., Becker, K. G., & Li, M. D. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.01.008 · Cited by 25
“Further, animal studies indicate that nicotine, like other drugs of abuse, stimulates the mesocorticolimbic dopamine system in the outer shell of the nucleus accumbens (NA) (Pontieri et al., 1996; Robbins and Everitt, 1999) and modulates the release of other neurotransmitters such as”
Nicotine sensitization of monkey striatal dopamine release
Domino, E. F., & Tsukada, H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.02.011 · Cited by 27
“…1988; Fuxe et al., 1988; Grenhoff and Svensson, 1988; Damsma et al., 1989; Lapin et al., 1989; Brazell et al., 1990; Corrigall and Coen, 1991; Corrigall et al., 1992, 1994; Nisell et al., 1994a,b; Marshall et al.,1997; Pontieri et al.,1996; Gardner,1997; Gerasimov et al., 2000; Di Chiara, 2002).”
Comments on risk for schizophrenia
Weiser, M., Davidson, M., & Noy, S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.05.005 · Cited by 27
Targeting glutamate homeostasis for potential treatment of nicotine dependence
Alasmari, F. F., Al-Rejaie, S. S., AlSharari, S. D., & Sari, Y. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.11.010 · Cited by 26
“The role of nicotine in the brain’s reward neurocircuitry has been investigated extensively (Pontieri et al., 1996, Reid et al., 2000, Saellstroem Baum et al., 2006, Goriounova and Mansvelder, 2012).”
BackgroundThe dopamine D2 receptor (DRD2) gene–a genetic risk factor in heavy smoking?
Batra, A., Gelfort, G., Bartels, M., Smoltczyk, H., Buchkremer, G., Rieß, O., & Schöls, L. J. (2000) · Addiction Biology · doi:10.1111/j.1369-1600.2000.tb00212.x · Cited by 27
Marenco, T., Bernstein, S., Cumming, P. D., & Clarke, P. B. S. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703005 · Cited by 25
“The e ects of nicotine on LCGU in freely-moving rats have been the subject of one previous report (Pontieri et al., 1996).”
BackgroundVecchiola, A., Collyer, P., Figueroa, R. E., Labarca, R., Bustos, G. A., & Magendzo, K. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00044-3 · Cited by 27
Schmidt, L. G., & Smolka, M. N. (2001) · Alcohol · doi:10.1016/s0741-8329(01)00129-x · Cited by 25
“This observation would be compatible with the coping or compensatory hypothesis as formulated by Rohsenow et al. (1997). This hypothesis suggests that tobacco may decrease the risk of drinking for abstinent alcoholics by providing a means of coping with urges to drink or with situations that pose a high risk for drink…”
BackgroundInfluentialRahman, S., Zhang, J., & Corrigall, W. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000035803.64724.17 · Cited by 26
“There was a significant time by treatment interaction, F (20, 10) 6.”
InfluentialDing, Y., Volkow, N. D., Logan, J., Garza, V., Pappas, N. R., King, P. T., & Fowler, J. S. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000301)35:3<234::aid-syn9>3.0.co;2-7 · Cited by 26
Ovarian Hormones Regulate Nicotine Consumption and Accumbens Glutamatergic Plasticity in Female Rats
Maher, E. E., Kipp, Z. A., Leyrer‐Jackson, J. M., Khatri, S., Bondy, E. O., Martinez, G. J., Beckmann, J. S., Hinds, T. D., Bimonte‐Nelson, H. A., & Gipson, C. D. (2022) · eNeuro · doi:10.1523/eneuro.0286-21.2022 · Cited by 25
“Nicotine signals via the nicotinic acetylcholine receptors (nAChRs) and through activating b 2-containing nAChRs, can increase dopamine release from the ventral tegmental area (VTA) into the NAcore (Pontieri et al., 1996; Mansvelder and McGehee, 2002; Mansvelder et al., 2002; Grieder et al., 2019).”
BackgroundLiu, X., Koren, A. O., Yee, S. K., Pechnick, R. N., Poland, R. E., & London, E. D. (2003) · Neuroreport · doi:10.1097/00001756-200308060-00020 · Cited by 25
Lotfipour, S., Arnold, M. M., Hogenkamp, D. J., Gee, K. W., Belluzzi, J. D., & Leslie, F. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.007 · Cited by 26
“, 2007b) and others (Pontieri et al., 1996).”
ResultMorud, J., Strandberg, J., Andrén, A., Ericson, M., Söderpalm, B., & Adermark, L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.002 · Cited by 25
“This is an open access article u subregions, e.g. in the nucleus accumbens (nAc) (De Biasi and Dani, 2011; Pontieri et al., 1996; Schilstrom et al., 2000; Zhou et al., 2001).”
BackgroundSmoking Cessation for Patients with Cardiovascular Disease: What is the Best Approach?
Joseph, A. M., & Fu, S. S. (2003) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200303050-00005 · Cited by 29
Smolka, M. N., Budde, H., Karow, A., & Schmidt, L. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1824-8 · Cited by 26
“Thus, the effects of nicotine on the NAcc are similar to those of other addictive drugs (Pontieri et al. 1996).”
BackgroundHeidbreder, C. A., Hédou, G., & Feldon, J. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00094-3 · Cited by 26
Dong, Y., Zhang, T., Li, W., Doyon, W., & Dani, J. A. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9231-6 · Cited by 23
“However, if the needle injection results in the administration of nicotine, which is capable of stimulating DA transmission (Pontieri et al. 1996; Balfour et al. 2000; Di Chiara 2000; Balfour 2004; Pidoplichko et al. 2004), then a naïve rat experiencing the needle injection will respond with a statistically greater DA…”
BackgroundInfluentialNicotine-, tobacco particulate matter- and methamphetamine-produced locomotor sensitisation in rats
Brennan, K. A., Putt, F., & Truman, P. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3071-3 · Cited by 23
“…Di Chiara 2000; Di Chiara and Imperato 1988; Iyaniwura et al. 2001), where microdialysis has shown that acute methamphetamine (Baumann et al. 2002; Miyata et al. 1996) and nicotine (Cadoni and Di Chiara 2000; Pontieri et al. 1996; Sziraki et al. 1999) administration increased DA dialysate levels.”
BackgroundInfluentialSmoking and BDNF Val66Met polymorphism in male schizophrenia: A case-control study
Zhang, X. Y., Chen, D., Tan, Y., Luο, X., Zuo, L., Lv, M., Shah, N. N., Zunta‐Soares, G. B., & Soares, J. C. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.09.023 · Cited by 23
“Preclinical studies show that nicotine activates dopaminergic neurons in the mesolimbic reward pathway enhancing DA release (Pontieri et al., 1996), which is associated with the pleasurable effects of the drug.”
BackgroundSecular trends in first hospitalizations for major mood disorders with comorbid substance use
Minnai, G. P., Tondo, L., Salis, P., Ghiani, C., Manfredi, A., Paluello, M. M., Baethge, C., & Baldessarini, R. J. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005948 · Cited by 25
“Such common mechanisms might, for example, include dopaminergic arousal and reward systems (Di Chiara et al., 1992 ; Pontieri et al., 1996 ; Robinson and Berridge, 2001).”
BackgroundTruman, P., Grounds, P., & Brennan, K. A. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2016.12.010 · Cited by 23
“All rights reserved. dopamine (Lewis et al., 2007; van Amsterdam et al., 2006) the reinforcement stimulus instigated by nicotine and most closely associated with addiction (Le Foll and Goldberg, 2009; Pontieri et al., 1996).”
BackgroundXu, Y., Zhang, Q., Li, P., Guangfeng, H., Wang, D., Liu, J., Zhou, H., Chai, G., Lu, B., He, S., et al. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05078 · Cited by 25
A Role for Sigma Receptors in Stimulant Self-Administration and Addiction
Katz, J. L., Hiranita, T., Hong, W. C., Job, M. O., & McCurdy, C. R. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_94 · Cited by 23
Luca, M. A. D., Bimpisidis, Z., Bassareo, V., & Chiara, G. D. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2220-9 · Cited by 26
“The response of NAc shell DA to drugs, however, in contrast to palatable food, is not subjected to one-trial habituation (Pontieri et al. 1995, 1996; Tanda et al. 1997; Bassareo and Di Chiara 1999).”
Self-citationBDNF Val66Met Variant and Smoking in a Chinese Population
Zhang, X. Y., Chen, D. C., Xiu, M. H., Luο, X., Zuo, L., Haile, C. N., Kosten, T. A., & Kosten, T. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053295 · Cited by 24
“Preclinical studies have demonstrated that nicotine activates dopaminergic neurons in the mesolimbic reward pathway and enhances DA release [7].”
BackgroundInfluence of acute and sub-chronic nicotine pretreatment on morphine state-dependent learning
Zarrindast, M., Nouraei, N., KHALLILZADEH, A., & ASKARI, E. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.06.032 · Cited by 23
Benowitz, N. L. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050012001 · Cited by 32
Wang, Y., Sherwood, J. L., Miles, C., Whiffin, G., & Lodge, D. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706621 · Cited by 24
“Systemic application of nicotine indeed induced DA release in the striatum and nucleus accumbens (Nisell et al., 1994a, b; Pontieri et al., 1996; Schilstrom et al., 1998; Fu et al., 2000), brain regions which are thought to contribute to the locomotor-stimulating and reinforcing actions of…”
BackgroundIs dopamine important in nicotine dependence?
Shoaib, M. C. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80024-7 · Cited by 26
McNair, L. F., & Kohlmeier, K. A. (2015) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174414000439 · Cited by 22
Sullivan, J. M., Kim, S., Cosgrove, K., & Morris, E. D. (2013) · Europe PMC (PubMed Central) · Cited by 26
Why are Antidepressant Drugs Effective Smoking Cessation Aids?
Shoaib, M. C., & Buhidma, Y. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170915142122 · Cited by 24
You, S., Li, X., Xiong, J., Zhu, X., Zhangsun, D., Zhu, X., & Luo, S. (2019) · Marine Drugs · doi:10.3390/md17090490 · Cited by 25
“This process was thought to explain the rewarding and reinforcing properties of nicotine [31,32].”
BackgroundBudzyńska, B., Polak, P., & Biała, G. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.003 · Cited by 23
Increased Suicidal Risk Among Smoking Schizophrenia Patients
Iancu, I., Sapir, A. P., Shaked, G., Poreh, A., Dannon, P. N., Chelben, J., & Kotler, M. (2006) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000228178.75711.eb · Cited by 22
Ethnic group differences in the relationship between depressive symptoms and smoking
Berg, C. J., Kirch, M., Hooper, M. W., McAlpine, D. D., An, L. C., Boudreaux, M. H., & Ahluwalia, J. S. (2012) · Ethnicity and Health · doi:10.1080/13557858.2012.654766 · Cited by 24
“1996 ); and (3) nicotine directly and indirectly affects the neurotransmitters involved in major depression (Hall et al .”
BackgroundRational treatment of addiction
Terenius, L. Y. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80132-4 · Cited by 22
Atrens, D. M. (2001) · Journal of Drug Issues · doi:10.1177/002204260103100202 · Cited by 23
“Nicotine also increases dopamine metabolism in the nucleus accumbens (Benwell, Holtom, Moran, & Balfour, 1996; Mirza, Pei, Stolerman, & Zetterstrom, 1996; Pontieri et al., 1996), and this is used as evidence that nicotine is addictive (Pich et aI.”
BackgroundInfluentialTwenty-first century tobacco use: it is not just a risk factor anymore
KHURANA, S., Batra, V., Patkar, A. A., & Leone, F. T. (2003) · Respiratory Medicine · doi:10.1053/rmed.2002.1443 · Cited by 30
Iversen, L. L. (1996) · Nature · doi:10.1038/382206a0 · Cited by 22
McGrath, D. S., Barrett, S. P., Stewart, S. H., & McGrath, P. R. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr294 · Cited by 23
Regulation by Nicotine of Gpr51 and Ntrk2 Expression in Various Rat Brain Regions
Sun, D., Huang, W., Hwang, Y. Y., Zhang, Y., Zhang, Q., & Li, M. D. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301134 · Cited by 21
“…of nicotine appear to be triggered through the stimulation of dopamine secretion in the ventral tegmental area (VTA), which projects to the nucleus accumbens (NA), in a manner similar to other drugs of abuse such as cocaine, amphetamine, or morphine (Pontieri et al, 1996; Rose and Corrigall, 1997).”
BackgroundExpanding treatment of tobacco dependence
Harris, D. S., & Anthenelli, R. M. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0034-3 · Cited by 22
“Special issues for women who smoke include the influence of menstrual cycle on cue-induced cigarette craving, the influence of hormone replacement therapy on treatment outcome [ 10 ], and pregnancy-related issues.”
BackgroundWang, F., Chen, H., & Sharp, B. M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05456.x · Cited by 23
The Effect of Cotinine on Nicotine- and Cocaine-Induced Dopamine Release in the Nucleus Accumbens
Sziráki, I., Sershen, H. W., Benuck, M., Lipovac, M. N., Hashim, A. T., Cooper, T. B., Allen, D., & Lajtha, Á. (1999) · Neurochemical Research · doi:10.1007/s11064-999-0001-1 · Cited by 22
Differential effects of cocaine on local cerebral glucose utilization in the mouse and in the rat
Zocchi, A., Conti, G., & Orzi, F. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01898-5 · Cited by 22
Self-citationJastrzębska, J., Nowak, E., Smaga, I., Bystrowska, B., Frankowska, M., Bäder, M., Filip, M., & Fuxé, K. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.03.002 · Cited by 24
“Nicotine and exposure to cigarette smoke increase DA turnover and release in the mesolimbic DA neurons which may mediate the reinforcing and locomotor activities of nicotine (Andersson et al., 1981; Fuxe et al., 1986; Imperato et al., 1986; Stolerman et al., 1995; Pontieri et al., 1996).”
Evidence of cross-tolerance between behavioural effects of nicotine and cocaine in mice
Desai, R. I., & Terry, P. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1319-4 · Cited by 22
“Moreover, increasing evidence suggests that the abuse-related effects of cocaine and nicotine may be mediated by a common neural substrate, specifically the mesolimbic dopamine system (e.g. Clarke 1990; Pontieri et al. 1996; Pich et al. 1997; for review, see Di Chiara 2000a).”
BackgroundAddressing Tobacco through Program and System Change in Mental Health and Addiction Settings
Stuyt, E. B., Order-Connors, B., & Ziedonis, D. M. (2003) · Psychiatric Annals · doi:10.3928/0048-5713-20030701-06 · Cited by 21
Functional correlates of heroin sensitization in the rat brain
Pontieri, F. E., Calò, L., Grezia, R. D., Orzi, F., & Passarelli, F. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01195-3 · Cited by 21
Self-citationDavidson, C., Ellinwood, E. H., & Lee, T. H. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00213-0 · Cited by 21
Hong, S. K., Jung, I. S., Bang, S. A., & Kim, S. E. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.09.052 · Cited by 20
Thuerauf, N., Lunkenheimer, J., Lunkenheimer, B., Sperling, W., Bleich, S., Schlabeck, M., Wiltfang, J., & Kornhuber, J. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0570-y · Cited by 20
“plays a role in the development of psychological dependency (Pontieri et al., 1996).”
BackgroundTanda, G., Li, S. M., Mereu, M., Thomas, A. M., Ebbs, A., Chun, L. E., Tronci, V., Green, J. L., Zou, M., Kopajtic, T. A., et al. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3109-6 · Cited by 20
“As has been shown previously for cocaine and 4-Cl-BZT (Tanda et al. 2005, 1997b), each of the compounds significantly increased DA concentrations in the NAC shell, an area of the brain implicated in the reinforcing effects of drugs (Pontieri et al. 1995, 1996; Tanda et al. 1997a).”
Self-citationWiesbeck, G. A., Wodarz, N., Weijers, H., Dürsteler‐MacFarland, K. M., Wurst, F. M., Walter, M., & Boening, J. (2006) · Neuropsychobiology · doi:10.1159/000093782 · Cited by 20
Beuten, J., Ma, J. Z., Lou, X., Payne, T. J., & Li, M. D. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30399 · Cited by 21
“Nicotine stimulates the release of dopamine from neurons in the ventral tegmental area (VTA), an action thought to underlie its rewarding effects [Nisell et al., 1994; Pontieri et al., 1996].”
BackgroundA novel nicotinic acetylcholine receptor antagonist radioligand for PET studies
Ding, Y., Kil, K.-E., Lin, K., Ma, W., Yokota, Y., & Carroll, I. F. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.075 · Cited by 21
Enemy within? The silent epidemic of substance dependency in GCC countries
Al‐Harthy, A., & Al‐Adawi, S. (2002) · Sultan Qaboos University medical journal · doi:10.18295/2075-0528.2591 · Cited by 20
Drugs: Drugs, economics and policy
Frey, B. S. (1997) · Economic Policy · doi:10.1111/1468-0327.t01-1-00025 · Cited by 20
Distinct temperature-dependent dopamine-releasing effect of drugs of abuse in the olfactory bulb
Vizi, E. S., Palkovits, M., Lendvai, B., Baranyi, M., Kovacs, K. J., & Zelles, T. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.12.010 · Cited by 20
“It is now known that nAChRs are localized on neurons of the mesolimbic dopaminergic system (Nisell et al., 1994; Pontieri et al., 1996; Mansvelder et al., 2002 ). Our finding that nicotine could evoke a large DA release from OB slices is indicative of the existence of nAChRs on local dopaminergic interneurons.”
BackgroundDrug therapy to aid in smoking cessation
Dale, L. C., Hurt, R. D., & Hays, J. T. (1998) · Postgraduate Medicine · doi:10.3810/pgm.1998.12.390 · Cited by 20
Anthenelli, R. M., & Maxwell, R. A. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04641.x · Cited by 20
The DRD2 Gene, Smoking, and Lung Cancer
Noble, E. P. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.5.343 · Cited by 22
Combinatorial synthesis of nicotine analogs using an Ugi 4-CR/cyclization-reduction strategy
Polindara‐García, L. A., & Vázquez, A. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00767k · Cited by 19
DuBois, D. W., Damborsky, J. C., Fincher, A. S., Frye, G. D., & Winzer‐Serhan, U. H. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.12.013 · Cited by 21
“Like nicotine, varenicline stimulates dopamine release (Rollema et al., 2007b; Pontieri et al., 1996; Quik et al., 2011) but the release is significantly smaller and longer lasting than that of nicotine, thereby diminishing reinforcement and craving of nicotine (Coe et al., 2005; Rollema et al.,…”
Nicotinic Receptors Underlying Nicotine Dependence: Evidence from Transgenic Mouse Models
Gipson, C. D., & Fowler, C. D. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_134 · Cited by 21
The Essential Oil from Angelica gigas NAKAI Suppresses Nicotine Sensitization
Zhao, R., Koo, B.-S., Kim, G. W., Jang, E. Y., Lee, J. R., Kim, M.-R., Kim, S. C., Kwon, Y. K., Kim, K. J., Huh, T., et al. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.2323 · Cited by 21
Nicotine Self-Administration in Animals: A Reevaluation
Dar, R., & Frenk, H. (2002) · Addiction Research & Theory · doi:10.1080/1606635021000041753 · Cited by 19
“According to this criterion, nicotine was clearly rewarding, as it was consistently reported to increase release of dopamine in the nucleus accumbens (e.g., Imperato et al., 1986; Clarke et al., 1988; Pontieri et al., 1996; Pich et al., 1997; Glick et al., 1998; Reid et al., 1998; Schilstrom et al., 1998), apparently…”
BackgroundChronic obstructive pulmonary disease
Hersh, C. P., & DeMeo, D. L. (2005) · CRC Press eBooks · doi:10.1201/b13341-13 · Cited by 19
Tang, X., Guo, S., Sun, H., Song, X., Jiang, Z., Sheng, L., Zhou, D., Hu, Y., & Chen, D. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328329893c · Cited by 20
Valdomero, A., Isoardi, N. A., Orsingher, O. A., & Cuadra, G. R. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.011 · Cited by 20
Huang, C., Chen, H., Huang, N., Yang, D., Kao, L., Chen, J., Lai, H., & Chern, Y. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722437.x · Cited by 21
“Most intriguing is that Pontieri et al. (1996) reported that intravenous administration of nicotine enhanced the extracellular dopamine levels as determined by brain microdialysis in the shell regions of the nucleus accumbens in the rat.”
InfluentialSharma, S., Archie, S. R., Kanchanwala, V., Mimun, K., Rahman, M. A., Zhang, Y., & Abbruscato, T. J. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.886099 · Cited by 18
Synaptic Plasticity Within Midbrain Dopamine Centers Contributes to Nicotine Addiction
Placzek, A. N., & Dani, J. A. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_2 · Cited by 18
“et al., 1994; Pidoplichko et al., 2004; Pontieri et al., 1996 ).”
BackgroundInfluentialPharmacotherapeutic Management of Nicotine Dependence in Pregnancy
Clark, S. M., & Nakad, R. (2011) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2011.02.017 · Cited by 20
“The rapid peak in plasma nicotine levels is quickly followed by a steady decline to the withdrawal stage, which triggers the next cigarette.(23) This repetitive”
BackgroundImplementation Intentions to Reduce Smoking: A Systematic Review of the Literature
Hagerman, C. J., Hoffman, R. K., Vaylay, S., & Dodge, T. L. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaa235 · Cited by 21
Liu, S., Ma, L., Guo, H., Feng, B., Guo, Y., Li, X., Sun, W., Zheng, L., & Zhao, M. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00338.x · Cited by 18
Bassareo, V., Cucca, F., Cadoni, C., Musio, P., & Chiara, G. D. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2856-0 · Cited by 18
“Drugs of abuse belonging to different pharmacological classes share the property of stimulating DA transmission preferentially in the NAc shell (Pontieri et al. 1995, 1996; Tanda et al. 1997; Bassareo et al. 2003; Aragona et al. 2008).”
BackgroundSelf-citationVarenicline does not increase serum BDNF levels in patients with nicotine dependence
Umene‐Nakano, W., Yoshimura, R., Yoshii, C., Hoshuyama, T., Hayashi, K., Hori, H., Katsuki, A., Ikenouchi‐Sugita, A., & Nakamura, J. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1113 · Cited by 18
Esmaeili, M. H., Sahraei, H., Ali-Beig, H., Ardehari-Ghaleh, M., Mohammadian, Z., Zardooz, H., Salimi, S. H., Shams, J., & Noroozzadeh, A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.04.015 · Cited by 18
“Based on anatomical and cytochemical differences, the NAc can be divided into core and shell subregions (Jongen-Relo et al., 1993, 1994; Meredith, 1999; Meredith et al., 1993), each having different roles in drug dependence (Pontieri et al., 1995, 1996; Smith et al., 2009).”
BackgroundVarenicline in smoking cessation
Tonstad, S., & Rollema, H. (2010) · Expert Review of Respiratory Medicine · doi:10.1586/ers.10.27 · Cited by 19
Segman, R. H., Kanyas, K., Karni, O., Lerer, E., Goltser‐Dubner, T., Pavlov, V., & Lerer, B. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30507 · Cited by 18
“Nicotine stimulates the release of dopamine via nicotinic receptors that are located on mesolimbic dopamine neurones [Pontieri et al., 1996].”
BackgroundShim, I., Won, J., Lee, J.-K., Song, D.-K., Kim, S. E., Huh, S., Kim, Y.-H., & Suh, H. (2000) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(99)00166-x · Cited by 19
“The current results are consistent with previous studies (Imperato et al., 1986; Damsma et al., 1989; Benwell and Balfour, 1992; Pontieri et al., 1996; Marshall et al., 1997), indicating that the mesolimbic DA system plays an important role in mediating addictive effects of nicotine.”
BackgroundResultThe most cited authors and papers in tobacco control
Byrne, F., & Chapman, S. F. (2005) · Tobacco Control · doi:10.1136/tc.2005.011973 · Cited by 20
Christensen, M. H., Nielsen, M. L., & Kohlmeier, K. A. (2015) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s204017441400049x · Cited by 17
Butts, S. F., Freeman, E. W., Sammel, M. D., Queen, K., Lin, H., & Rebbeck, T. R. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2216 · Cited by 18
Ehlinger, D. G., Burke, J. C., McDonald, C. G., Smith, R. F., & Bergstrom, H. C. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.036 · Cited by 18
“242 Nicotine is a potent reinforcing stimulus, making it among the most addictive substances known (Pontieri et al., 1996).”
Background
Metadata
- Authors
- Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D.
- Affiliations
- Sapienza University of Rome (IT)
- University of Cagliari (IT)
- Istituto Neurologico Mediterraneo (IT)
- Venue
- Nature
- Published
- 1996-07
- Volume
- 382
- Issue
- 6588
- Pages
- 255-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2000363595
- Cited by
- 1,073
- References
- 33
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 13 · 2023: 14 · 2022: 14 · 2021: 22 · 2020: 23 · 2019: 14 · 2018: 21 · 2017: 24 · 2016: 31 · 2015: 23 · 2014: 34 · 2013: 44 · 2012: 44
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotine, nicotine dependence, nucleus accumbens, energy metabolism, dopamine signaling, self-administration, cocaine, amphetamine, morphine, drug addiction, positive reinforcement, 2-deoxyglucose autoradiography, cerebral microdialysis
- MeSH terms
- Animals, Deoxyglucose, Dopamine, Energy Metabolism, Injections, Intravenous, Nicotine, Nucleus Accumbens, Microdialysis, Substance-Related Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.